Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0599 | -4.57251908397 | 1.31 | 1.35 | 1.14 | 22985 | 1.23665853 | CS |
4 | -0.2599 | -17.2119205298 | 1.51 | 1.7866 | 1.14 | 15504 | 1.45995942 | CS |
12 | -0.6599 | -34.5497382199 | 1.91 | 1.9799 | 1.14 | 13209 | 1.63211303 | CS |
26 | -0.6199 | -33.1497326203 | 1.87 | 2.18 | 1.14 | 11281 | 1.73317869 | CS |
52 | -1.2999 | -50.9764705882 | 2.55 | 3.2 | 1.14 | 11200 | 2.06371065 | CS |
156 | -1.9599 | -61.0560747664 | 3.21 | 4.45 | 1.14 | 14280 | 2.72934038 | CS |
260 | -1.9599 | -61.0560747664 | 3.21 | 4.45 | 1.14 | 14280 | 2.72934038 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約